return to news
  1. Molbio Diagnostics IPO allotment: How to check status online on KFin Technologies, NSE, BSE; listing date, time here

Market News

Molbio Diagnostics IPO allotment: How to check status online on KFin Technologies, NSE, BSE; listing date, time here

Journalist Kamal Joshi, former Republic TV and latestly news editor, currently associated with Upstox as senior ipo writer.

3 min read | Updated on August 13, 2026, 13:45 IST

SUMMARY

Molbio Diagnostics IPO allotment: The Goa-based company's ₹939.70 crore initial share sale comprised a fresh issue of shares valued at ₹200 crore and an offer-for-sale component of up to 91.66 lakh shares worth ₹739.70 crore by existing shareholders.

Molbio Diagnostics Ltd is a point-of-care diagnostics firm providing molecular testing for 30 diseases. | Image: molbiodiagnostics.com

Molbio Diagnostics Ltd is a point-of-care diagnostics firm providing molecular testing for 30 diseases. | Image: molbiodiagnostics.com

The basis of allotment of Molbio Diagnostics is likely to be finalised on Thursday, August 13. The bid finalisation details will be available on the websites of the NSE, the BSE and KFin Technologies.

Open FREE Demat Account within minutes!
Join now

The initial public offering received a total subscription of 70.26 times, as it got bids for 57,32,14,536 shares as against 81,58,529 shares on offer, as per the NSE data.

The portion for qualified institutional buyers (QIBs) got 186.39 times subscription. The quota for non-institutional investors (NIIs) was subscribed 49.80 times and that of retail individual investors 12.96 times.

The Goa-based company's ₹939.70 crore IPO comprised a fresh issue of shares valued at ₹200 crore and an offer-for-sale (OFS) component of up to 91.66 lakh shares worth ₹739.70 crore by existing shareholders.

The company intends to utilise ₹106 crore from the fresh issue proceeds towards capital expenditure for establishing infrastructure for an R&D facility, Centre of Excellence and connected office space.

Another ₹72 crore will be used towards the purchase of plant, machinery and other equipment for its Goa Unit I, Goa Unit II and Visakhapatnam unit, while the rest of funds will be used for corporate general purposes.

Incorporated in 2000, Molbio Diagnostics Ltd is a point-of-care diagnostics firm providing molecular testing for 30 diseases, including COVID, tuberculosis, HPV, HIV and Hepatitis B and C.

Its 'Truenat' platform, patented in over 100 countries for diagnosis of various infectious and non-communicable diseases, is a point-of-care polymerase chain reaction platform. The battery-operated platform can be used in resource-limited settings and facilitates decentralised diagnosis within an hour.

Molbio Diagnostics IPO allotment date and time

Molbio Diagnostics IPO allotment status is expected to be finalised on Thursday, August 13, 2026, by late evening.

Dhoot Transmission IPO allotment status: How to check online on NSE, BSE, KFin Technologies

How to check Molbio Diagnostics IPO allotment status online on NSE

Steps to check Molbio Diagnostics IPO allotment status online on BSE

  • Head to this link: https://bseindia.com/investors/appli_check.aspx
  • Issue type should be kept as 'Equity'
  • From the ‘Issue Name’ list, select 'Molbio Diagnostics'
  • Fill in your PAN or IPO application number
  • Click on the 'Search' button

Molbio Diagnostics IPO allotment status on KFin Technologies; step-by-step guide

  • Open this page: https://ipostatus.kfintech.com/
  • Pick 'Molbio Diagnostics' from the ‘Select IPO’ section
  • Identify yourself using PAN, Demat account number or IPO application number
  • Press the 'Submit' button

Molbio Diagnostics IPO listing date

Shares of Molbio Diagnostics will debut on the National Stock Exchange (NSE) and the BSE on Monday, August 17, at 10 am.

Disclaimer: This article is written purely for informational purposes and should not be considered investment advice from Upstox. Securities mentioned are illustrative and not recommendations. Please consult a financial advisor before making any investment decisions.

About The Author

Journalist Kamal Joshi, former Republic TV and latestly news editor, currently associated with Upstox as senior ipo writer.
Kamal Joshi is a business journalist who covers markets and IPOs. He places a special focus on in-depth analysis of DRHPs, RHPs and public-issue documents to produce data-driven stories. He covers trends across mainboard and SME IPOs, anchor allocations, subscription status and post-listing performance. He is passionate about breaking news and enjoys playing pickleball, especially flexing his net play. He was previously associated with Republic TV and LatestLY.

Next Story